ArticleClinical rheumatology2020
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Yanying Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleClinical rheumatology2020
Yanying Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.